Intravenous Vitamin C Lowers Mortality In Critically Ill Patients With Severe Pneumonia

In a recent study, researchers from the Tabriz University of Medical Sciences in Iran examine the effects of intravenous vitamin C on critically ill intensive care unit (ICU) patients with severe pneumonia. Published in the BMC Infectious Diseases journal, the study found that treatment with vitamin C was safe and could decrease inflammation, the duration of mechanical ventilation, and use of vasopressor medications such as norepinephrine (noradrenaline). Among the 40 patients in the control group, 11 deaths occurred. The group of 40 patients given vitamin C saw just 6 deaths. The study results add to the growing body of evidence supporting the use of vitamin C in the treatment of respiratory infections. The study was conducted in the form of a randomized double-blinded clinical trial. Patients received either a 60 milligrams per kilogram of bodyweight infusion of vitamin C per day for a period of 4 days, or a normal saline solution. Both groups of patients also received standard pneumonia treatment, including antibiotics. The patients had an average age of about 58. The researchers note that treatment with vitamin C is associated with an improvement in patients’ oxygenation levels. Based on their findings, they conclude that

Read more